Chemoinformaics analysis of Cissamine chloride
| Molecular Weight | 377.868 | nRot | 2 |
| Heavy Atom Molecular Weight | 353.676 | nRig | 21 |
| Exact Molecular Weight | 377.139 | nRing | 4 |
| Solubility: LogS | -0.908 | nHRing | 2 |
| Solubility: LogP | -0.317 | No. of Aliphatic Rings | 2 |
| Acid Count | 1 | No. of Aromatic Rings | 2 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 12 |
| nHA | 4 | APOL | 55.891 |
| nHD | 2 | BPOL | 29.829 |
| QED | 0.824 |
| Synth | 3.772 |
| Natural Product Likeliness | 2.014 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.997 |
| HIA | 0.987 |
| CACO-2 | -5.806 |
| MDCK | 0.00000652 |
| BBB | 0.127 |
| PPB | 0.253764 |
| VDSS | 1.657 |
| FU | 0.538499 |
| CYP1A2-inh | 0.02 |
| CYP1A2-sub | 0.931 |
| CYP2c19-inh | 0.027 |
| CYP2c19-sub | 0.534 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.285 |
| CYP2d6-inh | 0.047 |
| CYP2d6-sub | 0.917 |
| CYP3a4-inh | 0.005 |
| CYP3a4-sub | 0.683 |
| CL | 13.868 |
| T12 | 0.955 |
| hERG | 0.035 |
| Ames | 0.076 |
| ROA | 0.112 |
| SkinSen | 0.915 |
| Carcinogencity | 0.031 |
| EI | 0.037 |
| Respiratory | 0.102 |
| NR-Aromatase | 0.003 |
| Antiviral | Yes |
| Prediction | 0.655781 |